iOrganBio has appointed Karol Jarzabek as chief operating officer to [...]

iXCells Biotechnologies and Rosebud Biosciences have announced a partnership to [...]

PulseSight Therapeutics has completed dosing in its Phase 1 clinical [...]

Cellular Origins and Fresenius Kabi have completed the first phase [...]

ELRIG has unveiled the keynote speakers for its inaugural Cell [...]

Datwyler, LTS Device Technologies, and Stevanato Group have launched a [...]

AAVantgarde Bio has completed enrollment in LUCE-1, a first-in-human Phase [...]

iXCells Biotechnologies has appointed Steve Smith as chief executive officer, [...]

Enhanced Genomics has appointed Katerina Leftheris to its board of [...]

NanoSyrinx has appointed Thomas Farrell as chief executive officer and [...]